{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:13:39Z","timestamp":1792782819616,"version":"4.5.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"United States of America National Institute of Health NHLBI","award":["R01HL150115"],"award-info":[{"award-number":["R01HL150115"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00011-020-01413-2","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:10:56Z","timestamp":1603152656000},"page":"7-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["Inflammasome formation in the lungs of patients with fatal COVID-19"],"prefix":"10.1007","volume":"70","author":[{"given":"Stefano","family":"Toldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Bussani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Nuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Bonaventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo G.","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cannat\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra","family":"Pillappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Nana-Sinkam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Sime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1930-785X","authenticated-orcid":false,"given":"Antonio","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,20]]},"reference":[{"key":"1413_CR1","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708\u201320.","journal-title":"N Engl J Med"},{"key":"1413_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000509483","volume":"10","author":"G Iannaccone","year":"2020","unstructured":"Iannaccone G, Scacciavillani R, Del Buono MG, Camilli M, Ronco C, Lavie CJ, et al. Weathering the cytokine storm in COVID-19: therapeutic implications. Cardiorenal Med. 2020;10:277\u201387.","journal-title":"Cardiorenal Med"},{"key":"1413_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41420-019-0181-7","volume":"5","author":"CS Shi","year":"2019","unstructured":"Shi CS, Nabar NR, Huang NN, Kehrl JH. SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discov. 2019;5:101.","journal-title":"Cell Death Discov"},{"key":"1413_CR4","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3389\/fimmu.2020.01518","volume":"11","author":"TL Freeman","year":"2020","unstructured":"Freeman TL, Swartz TH. Targeting the NLRP3 inflammasome in severe COVID-19. Front Immunol. 2020;11:1518.","journal-title":"Front Immunol"},{"key":"1413_CR5","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","volume":"126","author":"A Abbate","year":"2020","unstructured":"Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res. 2020;126:1260\u201380.","journal-title":"Circ Res"},{"key":"1413_CR6","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/j.ijcard.2013.12.137","volume":"171","author":"S Toldo","year":"2014","unstructured":"Toldo S, Kannan H, Bussani R, Anzini M, Sonnino C, Sinagra G, et al. Formation of the inflammasome in acute myocarditis. Int J Cardiol. 2014;171:e119\u201321.","journal-title":"Int J Cardiol"},{"key":"1413_CR7","doi-asserted-by":"crossref","first-page":"e007582","DOI":"10.1161\/CIRCEP.119.007582","volume":"12","author":"J Kron","year":"2019","unstructured":"Kron J, Mauro AG, Bonaventura A, Toldo S, Salloum FN, Ellenbogen KA, et al. Inflammasome formation in granulomas in cardiac sarcoidosis. Circ Arrhythm Electrophysiol. 2019;12:e007582.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"271\u2013280","key":"1413_CR8","first-page":"e8","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(271\u2013280):e8.","journal-title":"Cell"},{"key":"1413_CR9","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","volume":"2","author":"G Cavalli","year":"2020","unstructured":"Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, et al. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020;2:e325\u201331.","journal-title":"Lancet Rheumatol"},{"key":"1413_CR10","doi-asserted-by":"publisher","first-page":"18951","DOI":"10.1073\/pnas.2009017117","volume":"117","author":"R Cauchois","year":"2020","unstructured":"Cauchois R, Koubi M, Delarbre D, Manet C, Carvelli J, Blasco VB, et al. Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19. Proc Natl Acad Sci USA. 2020;117:18951\u20133.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1413_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S2665-9913(20)30167-3","volume":"2","author":"C Ucciferri","year":"2020","unstructured":"Ucciferri C, Auricchio A, Dinicola M, Potere N, Abbate A, Cipollone F, et al. Canakinumab in a subgroup of patients with COVID-19. Lancet Rheumatol. 2020;2:457\u20138.","journal-title":"Lancet Rheumatol"},{"key":"1413_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30008","author":"A Vecchie","year":"2020","unstructured":"Vecchie A, Bonaventura A, Toldo S, Dagna L, Dinarello CA, Abbate A. IL-18 and infections: is there a role for targeted therapies? J Cell Physiol. 2020. https:\/\/doi.org\/10.1002\/jcp.30008.","journal-title":"J Cell Physiol"},{"key":"1413_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/his.14201","author":"JL Sauter","year":"2020","unstructured":"Sauter JL, Baine MK, Butnor KJ, Buonocore DJ, Chang JC, Jungbluth AA, et al. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies. Histopathology. 2020. https:\/\/doi.org\/10.1111\/his.14201.","journal-title":"Histopathology"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-020-01413-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-020-01413-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-020-01413-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T18:20:53Z","timestamp":1669227653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-020-01413-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1413"],"URL":"https:\/\/doi.org\/10.1007\/s00011-020-01413-2","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]},"assertion":[{"value":"13 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Toldo reports grants from Olatec, grants from Kiniksa during the conduct of the study. Dr. Bonaventura reports a travel award grant from Kiniksa, outside the submitted work. Dr. Abbate reports grants and personal fees from Olatec, grants from Novartis, grants and personal fees from Kiniksa, grants from Regeneron, during the conduct of the study. In addition, Dr. Abbate has a patent on a Cryopyrin inhibitor issued. All other authors report no conflicts relevant to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research was conducted on de-identified post-mortem samples; this research did not involve any human living subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics committee approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}